Nyxoah SA Share Holder Equity 2021-2024 | NYXH
Nyxoah SA share holder equity from 2021 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
| Nyxoah SA Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2023 | $106 |
| 2022 | $127 |
| 2021 | $176 |
| 2020 | $111 |
| Nyxoah SA Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2024-09-30 | $115 |
| 2024-06-30 | $129 |
| 2024-03-31 | $95 |
| 2023-12-31 | $106 |
| 2023-09-30 | $118 |
| 2023-06-30 | $126 |
| 2023-03-31 | $134 |
| 2022-12-31 | $127 |
| 2022-09-30 | $134 |
| 2022-06-30 | $147 |
| 2022-03-31 | $160 |
| 2021-12-31 | |
| 2021-03-31 | $110 |
| 2020-12-31 | $111 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $0.352B | $0.005B |
| Nyxoah SA is a medical technology company. It focused on the development and commercialization of solutions to treat Obstructive Sleep Apnea. Nyxoah SA is based in Belgium. | |||